• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年心房颤动患者循环过氧化物酶体增殖物激活受体 γ 受体蛋白的初步研究。

A pilot study of circulating PPAR-γ receptor protein in elderly patients with atrial fibrillation.

机构信息

Department of Geriatrics, Peking University First Hospital, Beijing, China.

出版信息

Arch Med Sci. 2012 Jul 4;8(3):471-6. doi: 10.5114/aoms.2012.29402.

DOI:10.5114/aoms.2012.29402
PMID:22852002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3400903/
Abstract

INTRODUCTION

The present study aimed to investigate the relationship between serum peroxisome proliferator-activated receptor-γ (PPAR-γ) protein concentration and inflammatory markers in elderly patients with atrial fibrillation (AF).

MATERIAL AND METHODS

We enrolled a total of 73 elderly patients: 45 with AF as the test group and 28 in sinus rhythm as a control group. We assayed serum PPAR-γ receptor protein, high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumour necrosis factor-α (TNF-α). The study protocol and written informed consent were approved by the Ethics Committee of Clinical Research, Peking University First Hospital.

RESULTS

The concentration of PPAR-γ receptor protein was lower in AF patients than that in the control group (p < 0.01), and the concentrations of hs-CRP, IL-6, and TNF-α were higher than those in the control group (all p < 0.01). The PPAR-γ level was negatively correlated with hs-CRP, IL-6, and left atrium diameter (LAD) level (all p < 0.05). On logistic regression analysis, PPAR-γ, hs-CRP, TNF-α and LAD level were associated with AF.

CONCLUSIONS

Elderly patients with AF show an inflammatory state and atrial remodeling. The PPAR-γ receptor protein concentration is inversely linked with inflammation in AF. As an important transcription factor regulating inflammatory gene expression, PPAR-γ may take part in the pathogenesis of AF.

摘要

简介

本研究旨在探讨老年心房颤动(AF)患者血清过氧化物酶体增殖物激活受体-γ(PPAR-γ)蛋白浓度与炎症标志物之间的关系。

材料与方法

共纳入 73 例老年患者:45 例为 AF 患者(试验组),28 例窦性心律患者(对照组)。检测血清 PPAR-γ 受体蛋白、高敏 C 反应蛋白(hs-CRP)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)。研究方案和书面知情同意书均获得北京大学第一医院临床研究伦理委员会批准。

结果

AF 患者的 PPAR-γ 受体蛋白浓度低于对照组(p<0.01),hs-CRP、IL-6 和 TNF-α 浓度均高于对照组(均 p<0.01)。PPAR-γ 水平与 hs-CRP、IL-6 和左心房直径(LAD)水平呈负相关(均 p<0.05)。Logistic 回归分析显示,PPAR-γ、hs-CRP、TNF-α 和 LAD 水平与 AF 相关。

结论

老年 AF 患者存在炎症状态和心房重构。AF 中 PPAR-γ 受体蛋白浓度与炎症呈负相关。作为调节炎症基因表达的重要转录因子,PPAR-γ 可能参与 AF 的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc2/3400903/fa664fd9a1dd/AMS-8-18823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc2/3400903/fa664fd9a1dd/AMS-8-18823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bc2/3400903/fa664fd9a1dd/AMS-8-18823-g001.jpg

相似文献

1
A pilot study of circulating PPAR-γ receptor protein in elderly patients with atrial fibrillation.老年心房颤动患者循环过氧化物酶体增殖物激活受体 γ 受体蛋白的初步研究。
Arch Med Sci. 2012 Jul 4;8(3):471-6. doi: 10.5114/aoms.2012.29402.
2
[Expression of peroxisome proliferator-activated receptor alpha and beta in peripheral blood mononuclear cells of non-vavular hypertensive atrial fibrillation patients].[非瓣膜性高血压心房颤动患者外周血单个核细胞中过氧化物酶体增殖物激活受体α和β的表达]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 May;44(3):383-7.
3
[Clinical value of detecting serum soluble CD163 level in patients with atrial fibrillation].[检测血清可溶性CD163水平在房颤患者中的临床价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Oct 20;36(10):1406-1409.
4
Downregulation of peroxisome proliferator-activated receptor-gamma expression in hypertensive atrial fibrillation.高血压性心房颤动中过氧化物酶体增殖物激活受体-γ表达下调。
Clin Cardiol. 2009 Jun;32(6):337-45. doi: 10.1002/clc.20566.
5
PPARγ agonist use and recurrence of atrial fibrillation after successful electrical cardioversion.过继性细胞免疫治疗 过继性细胞免疫治疗是一种利用患者自身免疫细胞来治疗疾病的方法。这种治疗方法涉及从患者体内提取免疫细胞,经过体外培养和扩增后,再将这些细胞输回患者体内,以增强患者的免疫系统,攻击肿瘤细胞或感染病毒的细胞。过继性细胞免疫治疗已经在多种癌症和传染病的治疗中得到了广泛的应用。
Hellenic J Cardiol. 2017 Sep-Oct;58(5):387-390. doi: 10.1016/j.hjc.2017.01.025. Epub 2017 Mar 24.
6
Impact of circulating monocyte CD36 level on atrial fibrillation and subsequent catheter ablation.循环单核细胞 CD36 水平对心房颤动及随后导管消融的影响。
Heart Rhythm. 2011 May;8(5):650-6. doi: 10.1016/j.hrthm.2010.12.036. Epub 2010 Dec 30.
7
Inflammation and Coagulation are Two Interconnected Pathophysiological Pathways in Atrial Fibrillation Pathogenesis.炎症与凝血是心房颤动发病机制中两条相互关联的病理生理途径。
J Inflamm Res. 2023 Oct 31;16:4967-4975. doi: 10.2147/JIR.S429892. eCollection 2023.
8
Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.单纯风湿性二尖瓣狭窄患者炎症与心房颤动之间的关系
J Heart Valve Dis. 2007 Sep;16(5):468-74.
9
Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.非诺贝特通过PPAR-α/沉默调节蛋白1/PGC-1α途径抑制心房颤动中的心房代谢重塑。
Br J Pharmacol. 2016 Mar;173(6):1095-109. doi: 10.1111/bph.13438. Epub 2016 Feb 18.
10
Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.过氧化物酶体增殖物激活受体γ基因多态性影响开始肾脏替代治疗的终末期肾病患者的全身炎症反应和生存率。
Atherosclerosis. 2005 Sep;182(1):105-11. doi: 10.1016/j.atherosclerosis.2005.01.033. Epub 2005 Feb 25.

引用本文的文献

1
ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPARγ.血管生成素样蛋白4通过上调过氧化物酶体增殖物激活受体γ来抑制血管紧张素II诱导的心房成纤维细胞的促纤维化功能。
Iran J Basic Med Sci. 2023;26(5):587-593. doi: 10.22038/IJBMS.2023.69196.15077.
2
ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway.血管生成素样蛋白4通过PPAR途径减轻血管紧张素II诱导的小鼠心房颤动和纤维化。
Cardiol Res Pract. 2021 Aug 9;2021:9935310. doi: 10.1155/2021/9935310. eCollection 2021.
3
Relationship between serum angiopoietin-like 4 levels and recurrence of atrial fibrillation.

本文引用的文献

1
Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus.吡格列酮对伴有 2 型糖尿病的阵发性心房颤动患者导管消融结局的有益影响。
Europace. 2011 Sep;13(9):1256-61. doi: 10.1093/europace/eur131. Epub 2011 May 7.
2
Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update.过氧化物酶体增殖物激活受体-γ 在动脉粥样硬化中的作用:最新研究进展。
Circ J. 2011;75(3):528-35. doi: 10.1253/circj.cj-11-0060. Epub 2011 Feb 11.
3
Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats.
血清血管生成素样蛋白 4 水平与心房颤动复发的关系。
J Int Med Res. 2021 Feb;49(2):300060520988393. doi: 10.1177/0300060520988393.
4
Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis.循环中的过氧化物酶体增殖物激活受体γ在系统性硬化症中升高。
Postepy Dermatol Alergol. 2020 Dec;37(6):921-926. doi: 10.5114/ada.2019.84746. Epub 2019 Apr 26.
5
Integrative analysis of transcriptome-wide association study data and mRNA expression profiles identified candidate genes and pathways associated with atrial fibrillation.转录组全关联研究数据与mRNA表达谱的综合分析确定了与心房颤动相关的候选基因和通路。
Heart Vessels. 2019 Nov;34(11):1882-1888. doi: 10.1007/s00380-019-01418-w. Epub 2019 May 7.
6
Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing.阿托伐他汀对快速心房起搏所致兔心房颤动模型心房重构的影响。
BMC Cardiovasc Disord. 2016 Jun 24;16(1):142. doi: 10.1186/s12872-016-0301-8.
7
Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis.过氧化物酶体增殖物激活受体γ对心脏纤维化至关重要。
PPAR Res. 2016;2016:2198645. doi: 10.1155/2016/2198645. Epub 2016 May 12.
8
Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.糖尿病患者的心房颤动:分子机制与治疗前景
Cardiovasc Diagn Ther. 2015 Oct;5(5):364-73. doi: 10.3978/j.issn.2223-3652.2015.06.03.
9
Impact of peroxisome proliferator-activated receptor γ on angiotensin II type 1 receptor-mediated insulin sensitivity, vascular inflammation and atherogenesis in hypercholesterolemic mice.过氧化物酶体增殖物激活受体γ对高胆固醇血症小鼠中血管紧张素II 1型受体介导的胰岛素敏感性、血管炎症和动脉粥样硬化形成的影响
Arch Med Sci. 2015 Aug 12;11(4):877-85. doi: 10.5114/aoms.2015.53309. Epub 2015 Aug 11.
10
Contact force mapping during catheter ablation for atrial fibrillation: procedural data and one-year follow-up.房颤导管消融术中的接触力测绘:操作数据和一年随访。
Arch Med Sci. 2014 May 12;10(2):266-72. doi: 10.5114/aoms.2014.42578. Epub 2014 May 13.
吡格列酮可减轻压力超负荷诱导的大鼠炎症性心房纤维化和心房颤动易感性。
Heart Rhythm. 2011 Feb;8(2):278-85. doi: 10.1016/j.hrthm.2010.10.029. Epub 2010 Oct 26.
4
Risk factors for atrial fibrillation: Not always severe heart disease, not always so 'lonely'.心房颤动的危险因素:不一定是严重的心脏病,也不一定那么“孤独”。
Cardiol J. 2010;17(5):437-42.
5
Role of inflammation and oxidative stress in atrial fibrillation.炎症和氧化应激在心房颤动中的作用。
Heart Rhythm. 2010 Apr;7(4):438-44. doi: 10.1016/j.hrthm.2009.12.009. Epub 2009 Dec 24.
6
Downregulation of peroxisome proliferator-activated receptor-gamma expression in hypertensive atrial fibrillation.高血压性心房颤动中过氧化物酶体增殖物激活受体-γ表达下调。
Clin Cardiol. 2009 Jun;32(6):337-45. doi: 10.1002/clc.20566.
7
Histopathological substrate for chronic atrial fibrillation in humans.人类慢性心房颤动的组织病理学基础。
Heart Rhythm. 2009 Apr;6(4):454-60. doi: 10.1016/j.hrthm.2009.01.010. Epub 2009 Jan 16.
8
Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease.过氧化物酶体增殖物激活受体在心血管系统健康和疾病中的意义。
Pharmacol Ther. 2009 Jun;122(3):246-63. doi: 10.1016/j.pharmthera.2009.03.003. Epub 2009 Mar 24.
9
New insights into mechanisms of atrial fibrillation.心房颤动机制的新见解。
Physiol Res. 2010;59(1):1-12. doi: 10.33549/physiolres.931651. Epub 2009 Feb 27.
10
Current concepts in the pathogenesis of atrial fibrillation.心房颤动发病机制的当前概念。
Am Heart J. 2009 Feb;157(2):243-52. doi: 10.1016/j.ahj.2008.10.009. Epub 2008 Dec 24.